Rheumatoid arthritis: strategy more important than agent

The Lancet

Volumn 374, Issue 9688, 2009, Pages 430-432

  Sokka, Tuulikki ^a   Pincus, Theodore ^b  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; RISK; SWEDEN; TREATMENT DURATION;

EID: 68049127969     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61432-X     Document Type: Note

References (10)

1. Pincus T., Sokka T., and Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 52 (2005) 1009-1019
2. Silman A.J. The changing face of rheumatoid arthritis: why the decline in incidence?. Arthritis Rheum 46 (2002) 579-581
3. Sokka T., and Pincus T. Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States. Rheumatology (Oxford) 47 (2008) 1543-1547
4. Sokka T., Kautiainen H., Pincus T., et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 10.1136/ard.2009.109983 published online July 31.
5. van Vollenhoven R.F., Ernestam S., and Geborek P. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate monotherapy in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised controlled trial. Lancet 374 (2009) 459-466
6. Möttönen T., Hannonen P., Leirisalo-Repo M., et al., for the FIN-RACo trial group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 353 (1999) 1568-1573
7. Grigor C., Capell H., Stirling A., et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364 (2004) 263-269
8. Goekoop-Ruiterman Y., de Vries-Bouwstra J.K., Allaart C.F., et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146 (2007) 406-415
9. Verstappen S.M.M., Jacobs J.W.G., van der Veen M.J., et al., on behalf of the Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66 (2007) 1443-1449
10. Hetland M.L., Stengaard-Pedersen K., Junker P., et al., for the CIMESTRA study group. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 67 (2008) 815-822